<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01005108</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 16108</org_study_id>
    <secondary_id>NCI-2009-01315</secondary_id>
    <nct_id>NCT01005108</nct_id>
  </id_info>
  <brief_title>Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors</brief_title>
  <official_title>Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and
      gabapentin to their respective placebo controls in the treatment of hot flashes in breast
      cancer patients. The investigators primary specific aim will focus on determining the
      magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2009</start_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Daily Hot Flash Diary (DHFD)-Primary Outcome (2 minutes per day)</measure>
    <time_frame>Daily starting from baseline until week 12 and again for one week at week 24.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographics -Covariates</measure>
    <time_frame>5 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hot Flash Related Daily Interference Scale (HFRDIS)-Secondary outcome</measure>
    <time_frame>3 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI) - Secondary outcome</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Fatigue Inventory (BFI) - Secondary Outcome</measure>
    <time_frame>3 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HADS - Secondary Outcome</measure>
    <time_frame>2 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Assessment Scale -Secondary Outcome</measure>
    <time_frame>30 seconds</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acupuncture Expectancy Scale (AES) - Secondary Aim</measure>
    <time_frame>1 minute</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creditability Rating of Acupuncture - Secondary Aim</measure>
    <time_frame>1 minute</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication and CAM Usage -Covariates</measure>
    <time_frame>5 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraph Movement Measuring Device</measure>
    <time_frame>24 hrs/day for 3 days</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Hot Flashes</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Use of Gabapentin as a control intervention to evaluate the relative effects and adverse events of acupuncture for hot flashes</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women 18 years or older with a history of Stage I, II or III breast cancer for at
             least 12 months.

          2. Have been seen by an oncologist within the previous 6-month period and determined to
             be free of disease by clinical examination and history;

          3. Experienced at least two hot flashes daily over the seven-day screening period as
             based on the Daily Hot Flash Diary.

          4. Hot flashes have been present for at least a month before study entry.

          5. Willing to use non-hormonal contraceptives during the duration of the study if patient
             is premenopausal.

        Exclusion Criteria:

          1. Having metastatic breast cancer ( IV)

          2. Currently on chemotherapy or radiation therapy as adjuvant treatment

          3. Started hormonal therapies such as tamoxifen or aromatase inhibitors within the last 4
             weeks; or plan to change or terminate hormonal therapies in the next 14 weeks.

          4. Started or changed with treatments for hot flashes, such as SSRIs or clonidine within
             the last 4 weeks; or plan to change or terminate these therapies in the next 14 weeks.

          5. Current use of estrogen and/or progestin.

          6. Pregnancy

          7. Breast feeding

          8. Bleeding disorder or current use of warfarin or heparin by patient history because of
             the use of needles.

          9. Previous use of gabapentin for hot flashes.

         10. Current use of any anti-convulsant.

         11. Renal dysfunction defined as serum creatinine concentration above 1.25 times the upper
             limit of normal

         12. Known allergy to gabapentin.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun J Mao, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abramson Cancer Center of the University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abramson Cancer Center of the Unviersity of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2009</study_first_submitted>
  <study_first_submitted_qc>October 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2009</study_first_posted>
  <last_update_submitted>July 31, 2017</last_update_submitted>
  <last_update_submitted_qc>July 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hot Flashes for Breast Cancer Patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

